Cargando…
Differential Diagnosis of Waldenström’s Macroglobulinemia and Early Management: Perspectives from Clinical Practice
Waldenström’s Macroglobulinemia (WM) is a clonal B-lymphocyte neoplasm characterized by the presence of IgM monoclonal protein and ≥10% bone marrow involvement with lymphoplasmacytic cells. Several mature B-cell and plasma cell disorders can potentially produce monoclonal IgM immunoglobulin and henc...
Autores principales: | Cingam, Shashank, Sidana, Surbhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394652/ https://www.ncbi.nlm.nih.gov/pubmed/36003901 http://dx.doi.org/10.2147/BLCTT.S259860 |
Ejemplares similares
-
Waldenström Macroglobulinemia: Clinical Presentation, Diagnosis, and Management
por: Hobbs, Miriam, et al.
Publicado: (2020) -
Waldenstrom macroglobulinemia: prognosis and management
por: Oza, A, et al.
Publicado: (2015) -
New developments in the management of Waldenström macroglobulinemia
por: Abeykoon, Jithma P, et al.
Publicado: (2017) -
Waldenstrom’s Macroglobulinemia: An Update
por: Mazzucchelli, Maddalena, et al.
Publicado: (2018) -
Managing Waldenström’s macroglobulinemia with BTK inhibitors
por: Buske, Christian, et al.
Publicado: (2022)